Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AK001 in Moderate to Severe Nasal Polyposis
NCT02734849Phase 2Completed
- Sponsor
- Allakos Inc.
- Start
- Apr 2016
- Primary completion
- Jan 2018
- Modality
- Monoclonal Antibodies
- Countries
- 6
01
Overview
A Phase 2 trial of AK001 in nasal polyps, sponsored by Allakos Inc.. Started Apr 2016; status: completed.
02
Drugs
AK001
03
Conditions
nasal polyps
Beyond the preview
Go deeper on NCT02734849.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02734849.